ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "CyTOF"

  • Abstract Number: 99 • 2019 ACR/ARP Annual Meeting

    Mass Cytometry Immunophenotyping of Synovial Fluid from Checkpoint Inhibitor Related Arthritis

    Runci Wang1, Karmela Kim Chan 2, Amy Cunningham-Bussel 3, Laura Donlin 4, Gregory Vitone 2, Aidan Tirpack 2, Caroline Benson 2, Gregory Keras 3, Anna Helena Jonsson 5, Michael Brenner 6, Anne Bass 7 and Deepak Rao 1, 1Brigham and women's hospital, Boston, MA, 2Hospital For Special Surgery, New York, 3Brigham and women's hospital, Boston, 4Hospital For Special Surgery, New York, NY, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 6Brigham and Women’s Hospital:, Boston, 7Hospital for Special Surgery/Weill Cornell Medicine, New York, NY

    Background/Purpose: Anti-PD-1/PD-L1 checkpoint inhibitor therapies have produced remarkable results in stimulating immune responses against tumors. Checkpoint inhibitor therapy can also trigger a variety of autoimmune…
  • Abstract Number: 1033 • 2019 ACR/ARP Annual Meeting

    Mass Cytometric Immunophenotyping Highlights a Dysregulated T cell-B Cell Axis in Patients with New-onset Lupus

    Ye Cao1, Stephen Alves 2, Corine Sinnette 3, Cameron Speyer 3, Gregory Keras 1, Yujie Qu 2, Joshua Keegan 4, James Lederer 4, Deepak Rao 3 and Karen Costenbader 3, 1Brigham and Women's Hospital, Boston, 2Merck, boston, 3Brigham and Women's Hospital, Boston, MA, 4BWH, Boston

    Background/Purpose: The immune cell subsets most altered early in SLE disease course remain unclear. Defining abnormalities in lymphocyte populations in patients with new-onset SLE may…
  • Abstract Number: 2734 • 2019 ACR/ARP Annual Meeting

    Signaling Lymphocytic Activation Molecule Family (SLAMF) Receptors Deregulation Is Implicated in the Altered Function of NK Cells in Systemic Lupus Erythematosus

    Morgane Humbel 1, Florence Bellanger 1, Craig Fenwick 2, Alice Horisberger 3, Camillo Ribi 3 and Denis Comte1, 1Service of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Epalinges, Vaud, Switzerland, 2Service of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Epalinhes, Vaud, Switzerland, 3Service of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Vaud, Switzerland

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by quantitative and qualitative deficiencies of immune cells. Natural killer (NK) cells are innate…
  • Abstract Number: 135 • 2018 ACR/ARHP Annual Meeting

    High Dimensional Analysis By Mass Cytometry and RNA-Sequencing Reveals Altered Frequency and Exhausted Features of CD4 T and MAIT Cells in Systemic Sclerosis

    Bhairav Paleja1, Andrea Hsiu Ling Low2, Pavanish Kumar1, Suzan Saidin1, Ahmad Lajam2, Camillus Chua3, Liyun Lai1 and Salvatore Albani4, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 2Singapore General Hospital, Singapore, Singapore, 3Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 4Translational Immunology Institute, Singhealth/Duke-NUS Acedemic Medical Centre, Singapore, Singapore

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterised by excessive fibrosis of skin and internal organs, and vascular dysfunction. Association of T and B…
  • Abstract Number: 1104 • 2018 ACR/ARHP Annual Meeting

    Mass Cytometry Analysis Detects Dysregulated T Cell Complement Responses in Diffuse Cutaneous Systemic Sclerosis

    Giuseppina Arbore1, Shahram Kordasti2, Claudia Kemper3,4,5, Dennis Hourcade6, Benedetta Costantini2, Leo Placais3, Lynne Mitchell6, Richard Ellis4, Christopher P. Denton7, David Abraham8 and Voon H. Ong8, 1Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy, 2Systems Cancer Immunology Lab, King's College London, London, United Kingdom, 3Laboratory of Molecular Immunology and the Immunology Center, National Institutes of Health, Washington, WA, 4School of Immunology and Microbial Sciences, King's College London, London, United Kingdom, 5Institute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany, 6Division of Rheumatology, Washington University School of Medicine, St Louis, WA, 7UCL Division of Medicine, Royal Free Campus, London, United Kingdom, 8Division of Medicine, University College London, London, United Kingdom

    Background/Purpose: Aberrant CD4+ T cell activation is implicated in disease progression in systemic sclerosis (SSc). Activated T cells release various cytokines that may drive inflammation,…
  • Abstract Number: 1832 • 2018 ACR/ARHP Annual Meeting

    Proteomic and Transcriptomic Profiling of Cells in Ankylosing Spondylitis Patients Identifies a Novel, Synovial-Resident CD8+ T Cell

    Zoya Qaiyum1, Eric Gracey2, Yuchen Yao2 and Robert D Inman3, 1Department of Immunology, University of Toronto, Toronto, ON, Canada, 2Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 3Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada

    Background/Purpose: Current data suggests that immune events in the gut may impact on joint inflammation in ankylosing spondylitis (AS) but what directs cells in the…
  • Abstract Number: 2029 • 2018 ACR/ARHP Annual Meeting

    Extended Phenotypic Immunome Characterization (EPIC): A Web-Based Immune Reference Atlas

    Joo Guan Yeo1,2, Pan Lu1, Thaschawee Arkachaisri1,2, Su Li Poh1, Fauziah Ally1, Jing Yao Leong3, Kee Thai Yeo1,2, Loshinidevi D/O Thana Bathi1, Yun June Angela Tan2, Seck Choon Elene Lee2 and Salvatore Albani1,4, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 2KK Women's and Children's Hospital, Singapore, Singapore, 3Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 4Translational Immunology Institute, Singhealth/Duke-NUS Acedemic Medical Centre, Singapore, Singapore

    Background/Purpose: An atlas of the developing immune system will aid in our understanding of its normal maturation and identification of disease-associated cell subsets. The availability…
  • Abstract Number: 2837 • 2018 ACR/ARHP Annual Meeting

    Diminished STAT-3 Phosphorylation and Associated Cell Pathways Characterize MMF-Treated Systemic Lupus Erythematosus Patients

    Samantha Slight-Webb1, Joel M. Guthridge1, Eliza Chakravarty1, Hua Chen1, Rufei Lu2, Krista M. Bean1, Holden T. Maecker3, Paul J. Utz4 and Judith A. James5, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Stanford University, Stanford, CA, 4Medicine, Stanford University School of Medicine, Stanford, CA, 5Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Mycophenolate mofetil (MMF) is a commonly used medication to treat major organ involvement in SLE, specifically in patients with lupus nephritis. The safety and…
  • Abstract Number: 2903 • 2018 ACR/ARHP Annual Meeting

    Single Cell Association Testing Identifies an Expanded Th1-Skewed Cytotoxic Effector CD4+ T Cell Subset in Rheumatoid Arthritis

    Chamith Fonseka1, Deepak Rao2, Nikola Teslovich3, Ilya Korsunsky4, Susan Hannes5, Kamil Slowikowski1, Michael Gurish6, Laura T. Donlin7, James A. Lederer8, Michael Weinblatt9, Elena Massarotti9, Jonathan Coblyn9, Simon Helfgott10, Derrick J. Todd11, Vivian P. Bykerk12, Elizabeth Karlson13, Joerg Ermann14, Yvonne C. Lee15, Michael Brenner16 and Soumya Raychaudhuri1,17, 1Divisions of Genetics and Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Human Immunology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Division of Genetics and Rheumatology, Department of Medicine, Harvard Medical School, Boston, MA, 4Division of Genetics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Division of Genetics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 6Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 7Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 8Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 9Brigham and Women's Hospital, Boston, MA, 10Division of Rheumatology, Brigham and Women’s Hospital, Boston, MA, 11Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 12Deptartment of Rheumatology, Hospital for Special Surgery, New York, NY, 13Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 14Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 15Northwestern University Feinberg School of Medicine, Chicago, IL, 16Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 17Program in Medical and Population Genetics, Broad Institute, Boston, MA

    Background/Purpose: Defining the precise CD4+ T cell subsets that are dysregulated in RA patients is critical to deciphering pathogenesis. Here we present Mixed effects modeling…
  • Abstract Number: 2946 • 2018 ACR/ARHP Annual Meeting

    T Peripheral Helper Cells Are Expanded in the Circulation of Active SLE Patients and Correlate with CD21low B Cells

    Deepak Rao1, Alexandra Bocharnikov2, Chamith Fonseka3, Joshua Keegan2, Betty Diamond4, Jennifer Anolik5, Peter Nigrovic1, Soumya Raychaudhuri3,6, James A. Lederer7 and Michael Brenner8, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Divisions of Genetics and Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Autoimmune Musculoskeletal and Hematopoietic Diseases, The Feinstein Institute for Medical Research, Manhasset, NY, 5Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 6Program in Medical and Population Genetics, Broad Institute of Massachusetts Technical Institute, Harvard University, Cambridge, MA, 7Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 8Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Pathologic T cell-B cell interactions and production of autoantibodies are hallmark features of SLE. T follicular helper (Tfh) cells are generally considered the principal…
  • Abstract Number: 2949 • 2018 ACR/ARHP Annual Meeting

    African American and European American SLE Patients with Variable Disease Activity Reveal Distinct Differences in B Cells and TLR7/8 Pathways

    Samantha Slight-Webb1, Miles C. Smith1, Holden T. Maecker2, Paul J. Utz3, Joel M. Guthridge1 and Judith A. James4, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Stanford University, Stanford, CA, 3Medicine, Stanford University School of Medicine, Stanford, CA, 4Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disorder with a heterogeneous clinical presentation and periods of waxing and waning disease. Heterogeneity in SLE is…
  • Abstract Number: 2420 • 2017 ACR/ARHP Annual Meeting

    Mass Cytometry Analysis of CD4+ T Cells in Patients with Rheumatoid Arthritis

    Laura Su1, Daniel del Alcazar2 and Adam Marc2, 1University of Pennsylvania, Philadelphia, PA, 2Medicine, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: CD4+ T cells play a key role in the initiation and progression of RA. Past studies have identified impaired function and regulation of several…
  • Abstract Number: 2637 • 2017 ACR/ARHP Annual Meeting

    A Novel Regulatory Antigen Presenting B Cell and Memory Regulatory T Cell Subsets Are Enriched during the Quiescent Phase of Childhood Onset Systemic Lupus Erythematosus

    Joo Guan Yeo1,2, Thaschawee Arkachaisri1,3, Lena Das1, Justin Hung Tiong Tan1, Jing Yao Leong2, Yun June Angela Tan4, Liyun Lai5, Loshinidevi D/O Thana Bathi2, Phyllis Chen2, Seck Choon Elene Lee1, Yun Xin Book1 and Salvatore Albani5,6, 1Rheumatology and Immunology Service, KK Women's and Children's Hospital, Singapore, Singapore, 2Singhealth Translational Immunology and Inflammation Centre (STIIC), Duke-NUS Medical School, Singapore, Singapore, 3Duke-NUS Medical School, Singapore, Singapore, 4Department of Paediatric Anaesthesia, KK Women's and Children's Hospital, Singapore, Singapore, 5SingHealth Translational Immunology and Inflammation Centre (STIIC), Duke-NUS Medical School, Singapore, Singapore, 6KK Women's and Children's Hospital, Singapore, Singapore

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a multi-factorial disease and the conventional oligo-dimensional investigative approach involving one or a few cell subsets at a time…
  • Abstract Number: 83 • 2017 ACR/ARHP Annual Meeting

    Whole Blood Stimulations Identify Elevated T Cell Cytokines and Altered Granulocyte/Dendritic Cell Signaling in SLE Patients with Variable Disease Activity

    Samantha Slight-Webb1, Krista M. Bean1, Holden T. Maecker2, Paul J. Utz3, Judith A. James4 and Joel M. Guthridge5, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 3Medicine, Stanford University School of Medicine, Stanford, CA, 4Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, OKC, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is characterized by loss of immune tolerance to self-antigens and periods of waxing and waning disease. The clinical aspects of…
  • Abstract Number: 297 • 2017 ACR/ARHP Annual Meeting

    Multiplexed Characterization of Circulating and Joint-Derived Human Neutrophils in Inflammatory Arthritis

    Ricardo Grieshaber Bouyer1, Olha Halyabar2, Anais Levescot1, Kacie Hoyt2, Lauren Henderson2 and Peter Nigrovic1,2, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Neutrophils are innate immune cells that play a central role in the initiation of inflammatory arthritis as well as mediating tissue damage. We sought…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology